Publicaciones (35) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

  2. Clinical Perspectives, Eligibility, and Success Criteria for Bariatric/Metabolic Surgery

    Advances in experimental medicine and biology, Vol. 1460, pp. 677-695

  3. Consenso del grupo de trabajo de los trastornos de la conducta alimentaria de SENPE (GTTCA-SENPE). Evaluación y tratamiento médico-nutricional en la anorexia nerviosa. Actualización 2023

    Nutricion hospitalaria, Vol. 41, Núm. 1, pp. 1-60

  4. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  5. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

  6. Differential mitochondrial adaptation and FNDC5 production in brown and white adipose tissue in response to cold and obesity

    Obesity

  7. Does the Prevalence of Obesity in the Different Regions of Spain Influence the Attitudes, Perception, and Barriers to Its Treatment?

    Obesity Facts, Vol. 17, Núm. 3, pp. 264-273

  8. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

    Obesity Facts, Vol. 17, Núm. 4, pp. 374-444

  9. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

    Journal of Hepatology, Vol. 81, Núm. 3, pp. 492-542

  10. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary

    Diabetologia

  11. Enhancing the management of chronic diseases in clinical practice: The CARABELA methodology

    Journal of Healthcare Quality Research, Vol. 39, Núm. 5, pp. 336-339

  12. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  13. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

  14. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?

    European Journal of Internal Medicine, Vol. 119, pp. 13-30

  15. High prevalence of venous thrombotic events in Cushing’s syndrome: data from ERCUSYN and details in relation to surgery

    European Journal of Endocrinology, Vol. 190, Núm. 1, pp. 75-85

  16. Impact of primary aldosteronism on kidney function: Results from the SPAIN-ALDO registry

    Journal of Hypertension, Vol. 42, Núm. 10, pp. 1805-1812

  17. Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

    Journal of Physiology and Biochemistry

  18. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

  19. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

    Endocrine, Vol. 84, Núm. 2, pp. 683-693

  20. Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions

    Journal of Biomedical Science, Vol. 31, Núm. 1